Rodrigo, Kerby Brylle L.

HRN: 04-15-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CEFTRIAXONE 1G (VIAL)
03/13/2026
03/20/2026
IV
1g
Q12
Acute Appendicitis
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: